Search Results - P. Rod Dunbar
- Showing 1 - 10 results of 10
-
1
-
2
Ex Vivo Human Adipose Tissue Derived Mesenchymal Stromal Cells (ASC) Are a Heterogeneous Population That Demonstrate Rapid Culture-Induced Changes by Anna E. S. Brooks, Anna E. S. Brooks, Megan Iminitoff, Eloise Williams, Tanvi Damani, Victoria Jackson-Patel, Vicky Fan, Joanna James, P. Rod Dunbar, P. Rod Dunbar, Vaughan Feisst, Vaughan Feisst, Hilary M. Sheppard, Hilary M. Sheppard
Published in Frontiers in Pharmacology (2020-02-01)Get full text
Article -
3
Recombinant adeno-associated virus serotype 6 efficiently transduces primary human melanocytes. by Hilary M Sheppard, James E Ussher, Daniel Verdon, Jennifer Chen, John A Taylor, P Rod Dunbar
Published in PLoS ONE (2013-01-01)Get full text
Article -
4
-
5
-
6
Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors by Saem Mul Park, Saem Mul Park, Chun-Jen J. Chen, Chun-Jen J. Chen, Daniel J. Verdon, Daniel J. Verdon, Marcus P. Y. Ooi, Anna E. S. Brooks, Anna E. S. Brooks, Richard C. W. Martin, Jon A. Mathy, Jon A. Mathy, Patrick O. Emanuel, P. Rod Dunbar, P. Rod Dunbar
Published in Frontiers in Immunology (2024-06-01)Get full text
Article -
7
A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancer by Luis Munoz-Erazo, Luis Munoz-Erazo, Saem Mul Park, Saem Mul Park, Shelly Lin, Shelly Lin, Chun-Jen J. Chen, Chun-Jen J. Chen, Lisa Y. Y. Zhou, Lisa Y. Y. Zhou, Janet L. Rhodes, Janet L. Rhodes, Taesung Jeon, Sonya Fenton, John L. McCall, Roslyn A. Kemp, Roslyn A. Kemp, P. Rod Dunbar, P. Rod Dunbar
Published in Frontiers in Immunology (2025-01-01)Get full text
Article -
8
Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors by Nicholas Waldron, P Rod Dunbar, Sanjeev Deva, Oh Kyu Yoon, John Ling, Kai-Wen Lin, Dung Thai, Latesh Lad, Ahmed A Othman, Jared M Odegard, Adele Y Wang, Jonathan Nazareno, Edmond Ang
Published in Journal for ImmunoTherapy of Cancer (2024-04-01)Get full text
Article -
9
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection by Harry L. Janssen, Young-Suk Lim, Hyung Joon Kim, Leonard Sowah, Cheng-Hao Tseng, Carla S. Coffin, Magdy Elkhashab, Sang Hoon Ahn, Anh-Hoa Nguyen, Diana Chen, Jeffrey J. Wallin, Simon P. Fletcher, Circe McDonald, Jenny C. Yang, Anuj Gaggar, Diana M. Brainard, Scott Fung, Yoon Jun Kim, Jia-Horng Kao, Wan-Long Chuang, Anna E. Brooks, P. Rod Dunbar
Published in JHEP Reports (2024-02-01)Get full text
Article -
10
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma by John F Thompson, Peter Hersey, Michael Millward, Paul Nathan, Weisan Chen, Ralph Venhaus, Andreas Behren, Cyril Fisher, Jonathan S Cebon, Martin Gore, Ian D Davis, Grant A McArthur, Euan Walpole, Mark Smithers, Vincenzo Cerundolo, P Rod Dunbar, Duncan MacGregor, Michael P N Findlay, T R Jeffry Evans, Jeremy Marsden, Angus G Dalgleish, Pippa G Corrie, Marples Maria, Margaret Brimble, Geoff Williams, Sintia Winkler, Heather M Jackson, Liliana Endo-Munoz, Candani S A Tutuka, Lloyd J Old, Dennis Haack, Eugene Maraskovsky
Published in Journal for ImmunoTherapy of Cancer (2020-05-01)Get full text
Article
